Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Centrexion
Centrexion
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
Fierce Biotech
Thu, 09/19/19 - 08:13 pm
Centrexion
IPOs
clinical trials
painkillers
CNTX-4975
osteoarthritis of the knee
A bruised Eli Lilly buys rights to Centrexion’s early-stage pain drug for $47.5M upfront
Endpoints
Tue, 05/28/19 - 10:09 am
Eli Lilly
non-opioid pain treatments
Centrexion
CNTX-0290
Centrexion steps back from IPO amid volatile market
BioCentury
Sat, 11/17/18 - 12:54 pm
Centrexion
IPOs
Ex-Pfizer CEO’s startup Centrexion gets $67M for PhIII painkiller
Endpoints
Tue, 01/2/18 - 11:07 am
Centrexion
Jeff Kindler
clinical trials
painkillers
New Pain Drug Likely To Face Price Challenges From Payers
Forbes
Mon, 06/26/17 - 09:44 am
painkillers
payers
CNTX-4975
Centrexion
osteoarthritis of the knee